Anticancer Effect and Immune Induction by Hyperthermia of Malignant Melanoma Using Magnetite Cationic Liposomes
Overview
Affiliations
The hyperthermic effect of magnetic particles was examined in an in vivo study of mouse B16 melanoma. Magnetite cationic liposomes (MCLs) have a positive surface charge and generate heat under an alternating magnetic field (AMF) by hysteresis loss. MCLs were injected into melanoma nodules, which were then subjected to an AMF. The mice were divided into four groups: group I (control), group II (hyperthermia at 43 degrees C for 30 min, once), group III (hyperthermia at 46 degrees C for 30 min, once) and group IV (hyperthermia at 46 degrees C for 30 min, twice). Complete tumour regression was observed in 90% of the mice in group IV, while no mice in groups I and II and only 40% in group III showed regression. To examine whether hyperthermia caused immune induction in B16 melanoma, in vitro cytotoxicity assays and rechallenge experiments were performed. Cytotoxic activity was observed in the spleen cells of the cured mice in group IV. In the rechallenge experiment, 66% of the cured mice rejected melanoma cells. These results suggest that hyperthermia using MCLs is an effective therapy for melanoma, since this treatment can kill the tumour cells not only by heat but also by inducing an immune response.
Huang L, Zhao X, Zhang J, Zhang J, Liao W, Fan Y Nanoscale Adv. 2024; 7(2):601-613.
PMID: 39650616 PMC: 11622858. DOI: 10.1039/d4na00295d.
Mathematical modeling of heat transfer in tissues with skin tumor during thermotherapy.
Sherief H, Zaky M, Abbas M, Mahrous S PLoS One. 2024; 19(5):e0298256.
PMID: 38753701 PMC: 11098337. DOI: 10.1371/journal.pone.0298256.
Huang P, Chaney E, Aksamitiene E, Barkalifa R, Spillman Jr D, Bogan B Theranostics. 2021; 11(12):5620-5633.
PMID: 33897871 PMC: 8058715. DOI: 10.7150/thno.55333.
Modulating the Heat Stress Response to Improve Hyperthermia-Based Anticancer Treatments.
Scutigliani E, Liang Y, Crezee H, Kanaar R, Krawczyk P Cancers (Basel). 2021; 13(6).
PMID: 33808973 PMC: 8001574. DOI: 10.3390/cancers13061243.
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.
Soetaert F, Korangath P, Serantes D, Fiering S, Ivkov R Adv Drug Deliv Rev. 2020; 163-164:65-83.
PMID: 32603814 PMC: 7736167. DOI: 10.1016/j.addr.2020.06.025.